Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Barbara Garcia

Nurse Practitioner, Pediatrics Tampa, FL Nurse Practitioner

NPI 1639749211 CMS profile 10526368

4714 N Armenia Ave, Tampa, FL 33603

Open in the dashboard

General payments

$7,837

366 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Barbara Garcia of Tampa, FL is reported in the CMS Open Payments database as having received $7,837 across 366 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $891 39
2024 General $2,016 89
2023 General $2,249 105
2022 General $1,821 90
2021 General $860 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Barbara Garcia
  • Nurse Practitioner, Pediatrics median
  • Middle half of Nurse Practitioner, Pediatrics
  • National median

In program year 2025, general payments to Barbara Garcia were reported at $891. Among 7,458 Nurse Practitioner, Pediatrics profiles paid that year, the median was $93 and the middle half received between $35 and $201.

Show as a table
Year Barbara Garcia Nurse Practitioner, Pediatrics median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $860 $60 $23–$142 $132
2022 $1,821 $72 $27–$161 $149
2023 $2,249 $89 $35–$185 $160
2024 $2,016 $93 $34–$199 $164
2025 $891 $93 $35–$201 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AstraZeneca Pharmaceuticals LP $1,547 66 payments
  2. Baxter Healthcare $843 44 payments
  3. Amgen Inc. $728 46 payments
  4. Sobi, Inc $723 34 payments
  5. Regeneron Healthcare Solutions, Inc. $711 34 payments
  6. Genzyme Corporation $700 34 payments
  7. GlaxoSmithKline, LLC. $512 23 payments
  8. Genentech USA, Inc. $434 18 payments
  9. Novartis Pharmaceuticals Corporation $370 14 payments
  10. Covis Pharma B.V. $253 8 payments
  11. Other $1,016 45 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,773 365 payments
  2. Education $64 1 payment
Products named General payments · program years 2021–2025
  1. FASENRA $1,384 56 payments
  2. Hillrom - Vest System Model 105 Home Care $843 44 payments
  3. SYNAGIS $723 34 payments
  4. DUPIXENT Immunology $700 34 payments
  5. TEZSPIRE Inflammation $638 41 payments
  6. NUCALA $512 23 payments
  7. DUPIXENT Inflammation And Immunology $427 27 payments
  8. TEZSPIRE Respiratory $393 13 payments
  9. Xolair Immunology $392 14 payments
  10. XOLAIR Pulmonary/Respiratory Diseases $370 14 payments
  11. Other $1,550 66 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

366 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Pediatrics in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record